Showing results (111-120 of 194) with videos related to

Sort By:
Pageof 20
Current Medical Research and Opinion|January 1, 1979
A double-blind, crossover trial of mefenamic acid, sulindac and flurbiprofen in rheumatoid arthritisW H Stephens, A F El-Ghobarey, M M Macleod, et al.
The Journal of Rheumatology|December 1, 1988
Validation study of WOMAC: a health status instrument for measuring clinically important patient relevant outcomes to antirheumatic drug therapy in patients with osteoarthritis of the hip or kneeN Bellamy, W W Buchanan, C H Goldsmith, et al.
Zeitschrift Fur Rheumatologie|January 1, 1975
[Evaluation of phenylalkanoic acid derivatives in the management of rheumatic diseases as well as various explanations on the doctrine of clinical research technics]R D Sturrock, D Grennan, P Lee, et al.
Clinical Therapeutics|July 1, 1992
Safety and efficacy of etodolac compared with piroxicam in patients with degenerative joint disease of the kneeW C Dick, S Bulstra, G H Schardijn, et al.
The Journal of Rheumatology|January 1, 1992
Double blind randomized controlled trial of sodium meclofenamate (Meclomen) and diclofenac sodium (Voltaren): post validation reapplication of the WOMAC Osteoarthritis IndexN Bellamy, W F Kean, W W Buchanan, et al.
British Journal of Clinical Pharmacology|June 1, 1984
Clinical evaluation of two strategies for improving patient recall of prior drug therapyN Bellamy, E Grace, B Hanna, et al.
Annals of the Rheumatic Diseases|January 1, 1992
HLA-D region genes and rheumatoid arthritis (RA): importance of DR and DQ genes in conferring susceptibility to RAD P Singal, D Green, B Reid, et al.
Arthritis and Rheumatism|August 1, 1982
Prior gold therapy does not influence the adverse effects of D-penicillamine in rheumatoid arthritisW F Kean, C J Lock, H E Howard-Lock, et al.
Annals of the Rheumatic Diseases|April 1, 1989
A study of headaches and migraine in Sjögren's syndrome and other rheumatic disordersB Pal, C Gibson, J Passmore, et al.
Agents and Actions|February 1, 1976
A novel relationship between plasma kininogen and rheumatoidJ N Sharma, I J Zeitlin, P M Brooks, et al.
Pageof 20